FORTREA HOLDINGS INC. (FTRE) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $100.00K; Additional Paid in CapitalUSD $2.14B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-196.50M; Retained Earnings (Accumulated Deficit)USD $-1.42B.
- 2026-03-31: Common Stock, Value, IssuedUSD $100.00K; Additional Paid in CapitalUSD $2.13B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-195.40M; Retained Earnings (Accumulated Deficit)USD $-1.41B.
- 2025-12-31: Common Stock, Value, IssuedUSD $100.00K; Additional Paid in CapitalUSD $2.12B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-170.00M; Retained Earnings (Accumulated Deficit)USD $-1.38B.
- 2025-09-30: Common Stock, Value, IssuedUSD $100.00K; Additional Paid in CapitalUSD $2.10B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-170.40M; Retained Earnings (Accumulated Deficit)USD $-1.35B.
FORTREA HOLDINGS INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Other USD |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $100.00K | $2.14B | $-196.50M | $-1.42B | $524.20M | 3 month · $12.60M | (m) |
| 2026-03-31 | $100.00K | $2.13B | $-195.40M | $-1.41B | $525.90M | 3 month · $11.40M | (m) |
| 2025-12-31 | $100.00K | $2.12B | $-170.00M | $-1.38B | $563.50M | 12 month · $74.40M | (m) |
| 2025-09-30 | $100.00K | $2.10B | $-170.40M | $-1.35B | $580.80M | 3 month · $22.30M | (m) |
| 2025-06-30 | $100.00K | $2.08B | $-155.60M | $-1.33B | $589.20M | 3 month · $22.70M | (m) |
| 2025-03-31 | $100.00K | $2.06B | $-238.20M | $-959.90M | $858.80M | 3 month · $14.60M | (m) |
| 2024-12-31 | $100.00K | $2.04B | $-282.90M | $-397.00M | $1.36B | 12 month · $58.40M | (m) |
| 2024-09-30 | $100.00K | $2.03B | $-178.10M | $-335.80M | $1.51B | 3 month · $13.00M | (m) |
| 2024-06-30 | $100.00K | $2.02B | $-249.00M | $-307.90M | $1.46B | 3 month · $15.00M | (m) |
| 2024-03-31 | $100.00K | $2.00B | $-241.60M | $-169.50M | $1.59B | 3 month · $15.10M | 3 month · $200.00K |
| 2023-12-31 | $100.00K | $2.00B | $-215.50M | $-68.50M | $1.71B | 12 month · $26.60M | (m) |
| 2023-09-30 | $100.00K | $1.99B | $-280.30M | $-13.10M | $1.69B | 3 month · $11.10M | (m) |
| 2023-06-30 | $100.00K | $1.98B | $-225.50M | (m) | $1.75B | (m) | (m) |
| 2023-03-31 | (m) | (m) | (m) | (m) | $3.40B | (m) | (m) |
| 2022-12-31 | $0.00 | $0.00 | $-276.00M | $0.00 | $3.34B | (m) | (m) |
| 2022-09-30 | (m) | (m) | (m) | (m) | $3.22B | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) | $3.30B | (m) | (m) |
| 2022-03-31 | (m) | (m) | (m) | (m) | $3.35B | (m) | (m) |
| 2021-12-31 | (m) | (m) | (m) | (m) | $3.26B | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) | (m) | $3.29B | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |